KSHB: Saint Luke’s Launches Global Clinical Trial to Investigate Potential COVID-19 Treatment KSHB: Saint Luke’s Launches Global Clinical Trial to Investigate Potential COVID-19 Treatment ehohenberg Fri, 04/24/2020 - 12:24

Saint Luke’s Mid America Heart Institute launches a global clinical trial to investigate whether the diabetes drug dapagliflozin could be a treatment for patients with COVID-19. 


Dr. Mikhail Kosiborod, Saint Luke's cardiologist, is serving as the principal investigator for the study which will enroll 900 patients globally.

Organizations

Saint Luke's Mid America Heart Institute

News Serviceline Category

Research Heart

Read more

Related Content

Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more
Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more